Name | Number of supported studies | Average coverage | |
---|---|---|---|
basal cell | 3 studies | 41% ± 23% |
Insufficient scRNA-seq data for expression of IL20RB at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 39% | 3916.24 | 564 / 1445 | 74% | 45.34 | 136 / 183 |
skin | 97% | 11026.36 | 1763 / 1809 | 13% | 2.82 | 61 / 472 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.86 | 1 / 1 |
tonsil | 0% | 0 | 0 / 0 | 96% | 151.70 | 43 / 45 |
uterus | 1% | 87.82 | 2 / 170 | 73% | 113.95 | 336 / 459 |
pancreas | 0% | 0 | 0 / 328 | 59% | 15.24 | 105 / 178 |
lung | 0% | 1.98 | 1 / 578 | 55% | 27.38 | 633 / 1155 |
bladder | 0% | 0 | 0 / 21 | 42% | 20.91 | 211 / 504 |
kidney | 0% | 0 | 0 / 89 | 32% | 18.07 | 288 / 901 |
liver | 11% | 128.15 | 24 / 226 | 13% | 1.89 | 52 / 406 |
prostate | 9% | 139.50 | 23 / 245 | 5% | 0.28 | 27 / 502 |
intestine | 0% | 0 | 0 / 966 | 14% | 3.03 | 76 / 527 |
stomach | 1% | 6.57 | 2 / 359 | 13% | 1.45 | 36 / 286 |
thymus | 0% | 1.21 | 1 / 653 | 10% | 0.58 | 62 / 605 |
ovary | 0% | 0 | 0 / 180 | 10% | 0.52 | 44 / 430 |
breast | 1% | 9.65 | 5 / 459 | 7% | 1.39 | 81 / 1118 |
brain | 0% | 0 | 0 / 2642 | 5% | 0.22 | 37 / 705 |
adipose | 3% | 39.20 | 32 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 0% | 0 | 0 / 258 | 2% | 1.21 | 5 / 230 |
blood vessel | 1% | 8.04 | 7 / 1335 | 0% | 0 | 0 / 0 |
heart | 0% | 4.26 | 4 / 861 | 0% | 0 | 0 / 0 |
muscle | 0% | 2.75 | 1 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
GO_0032689 | Biological process | negative regulation of type II interferon production |
GO_0043029 | Biological process | T cell homeostasis |
GO_0019221 | Biological process | cytokine-mediated signaling pathway |
GO_0002437 | Biological process | inflammatory response to antigenic stimulus |
GO_0002765 | Biological process | immune response-inhibiting signal transduction |
GO_0032733 | Biological process | positive regulation of interleukin-10 production |
GO_0032753 | Biological process | positive regulation of interleukin-4 production |
GO_0042130 | Biological process | negative regulation of T cell proliferation |
GO_0032703 | Biological process | negative regulation of interleukin-2 production |
GO_0042098 | Biological process | T cell proliferation |
GO_0048873 | Biological process | homeostasis of number of cells within a tissue |
GO_0001808 | Biological process | negative regulation of type IV hypersensitivity |
GO_0005886 | Cellular component | plasma membrane |
GO_0042015 | Molecular function | interleukin-20 binding |
GO_0005515 | Molecular function | protein binding |
GO_0004896 | Molecular function | cytokine receptor activity |
Gene name | IL20RB |
Protein name | Interleukin-20 receptor subunit beta (IL-20 receptor subunit beta) (IL-20R-beta) (IL-20RB) (Fibronectin type III domain containing 6) (FNDC6) (IL-20R2) Interleukin 20 receptor subunit beta |
Synonyms | UNQ557/PRO1114 DIRS1 |
Description | FUNCTION: The IL20RA/IL20RB dimer is a receptor for IL19, IL20 and IL24. The IL22RA1/IL20RB dimer is a receptor for IL20 and IL24. |
Accessions | H7C5S5 F8WAV8 Q6UXL0 F8WC67 ENST00000329582.9 [Q6UXL0-1] ENST00000491483.5 ENST00000469964.5 ENST00000475972.1 |